Contents
Inflammation & Allergy - Drug Targets (Discontinued), Volume 13 - Number 4
The Gut Microbiome
, 13(4): 217 - 223Giovanni C. Actis
DOI: 10.2174/1871528113666140623113221
The Gut Microbiome
ACE and ACE2 in Inflammation: A Tale of Two Enzymes
, 13(4): 224 - 234Ravinder Reddy Gaddam, Stephen Chambers and Madhav Bhatia
DOI: 10.2174/1871528113666140713164506
ACE and ACE2 in Inflammation: A Tale of Two Enzymes
HSP70 Family in the Renal Inflammatory Response
, 13(4): 235 - 240Walter Manucha
DOI: 10.2174/1871528113666140805125632
HSP70 Family in the Renal Inflammatory Response
Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs
, 13(4): 241 - 248Saida Rezakovic, Zrinjka Pastar and Kresimir Kostovic
DOI: 10.2174/1871528113666140717113358
Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs
An Update on Disease Modifying Antirheumatic Drugs
, 13(4): 249 - 261Poorvashree Joshi and Suneela S. Dhaneshwar
DOI: 10.2174/187152811304140915152102
An Update on Disease Modifying Antirheumatic Drugs
Dengue Fever: Theories of Immunopathogenesis and Challenges for Vaccination
, 13(4): 262 - 274Melissa M. Remy
DOI: 10.2174/1871528113666140828113158
Dengue Fever: Theories of Immunopathogenesis and Challenges for Vaccination
Biologics for ANCA-Associated Vasculitis
, 13(4): 275 - 287Giuseppe Murgia, Davide Firinu, Paolo E. Manconi and Stefano R. Del Giacco
DOI: 10.2174/1871528113666140702094456
Biologics for ANCA-Associated Vasculitis
Webmaster Contact: info@benthamscience.org